These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7492817)

  • 21. Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer.
    Abe Y; Matsuzawa T; Fujiwara T; Itoh M; Fukuda H; Yamaguchi K; Kubota K; Hatazawa J; Tada M; Ido T
    Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):1005-10. PubMed ID: 2170302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
    Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
    Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
    Bachor R; Kocher F; Gropengiesser F; Reske SN; Hautmann RE
    Urologe A; 1995 Mar; 34(2):138-42. PubMed ID: 7754585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
    Mucha SA; Kunert-Radek J; Pomorski L
    Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator].
    Trampert L; Holle LH; Berberich R; Alexander C; Ukena D; Ruth T; Sybrecht GW; Oberhausen E
    Nuklearmedizin; 1995 Jun; 34(3):79-86. PubMed ID: 7630746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.
    Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ
    Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases.
    Melloni B; Monteil J; Vincent F; Bertin F; Gaillard S; Ducloux T; Verbeke S; Maubon A; Vandroux JC; Bonnaud F
    Eur Respir J; 2004 Nov; 24(5):814-21. PubMed ID: 15516678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer diagnosis with positron emission tomography (PET)].
    Kubota K
    Kaku Igaku; 1996 Feb; 33(2):207-12. PubMed ID: 8721109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography.
    Taylor IK; Hill AA; Hayes M; Rhodes CG; O'Shaughnessy KM; O'Connor BJ; Jones HA; Hughes JM; Jones T; Pride NB; Fuller RW
    Lancet; 1996 Apr; 347(9006):937-40. PubMed ID: 8598758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
    Hooft L; Hoekstra OS; Devillé W; Lips P; Teule GJ; Boers M; van Tulder MW
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3779-86. PubMed ID: 11502811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined role of tumor markers and 18fluoro-deoxyglucose-positron emission tomography (18FDG-PET) in follow-up of cancer patients].
    Lamy PJ; Comte F; Eberlé MC
    Bull Cancer; 2005 Oct; 92(10):858-64. PubMed ID: 16266869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]fluorodeoxyglucose uptake in neonatal acute lung injury measured by positron emission tomography.
    Kirpalani H; Abubakar K; Nahmias C; deSa D; Coates G; Schmidt B
    Pediatr Res; 1997 Jun; 41(6):892-6. PubMed ID: 9167204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
    Salaun PY; Abgral R; Querellou S; Couturier O; Valette G; Bizais Y; Kraeber-Bodéré F
    Head Neck; 2007 Dec; 29(12):1115-20. PubMed ID: 17636537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.
    Bernsdorf M; Graff J
    Clin Physiol Funct Imaging; 2014 Nov; 34(6):426-33. PubMed ID: 24267489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and prognosis in neuro-oncology: contribution of positron emission tomography].
    Derlon JM
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):854-7. PubMed ID: 11677408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between PET-CT 18FDG uptake in primary lesions and clinicopathological parameters in esophageal carcinoma patients].
    Feng R; Li MH; Kong L; Shi F; Yang GR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):452-4. PubMed ID: 19950557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simplified measurement of deoxyglucose utilization rate.
    Hunter GJ; Hamberg LM; Alpert NM; Choi NC; Fischman AJ
    J Nucl Med; 1996 Jun; 37(6):950-5. PubMed ID: 8683318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.